A panel of 20 proteins in blood may be used to quantify disease activity, namely relapses and lesions, in people with multiple sclerosis (MS), a new paper proposes.
“A multi-protein panel like the one developed in this study has the capability to capture the state of a patient’s MS from…
[ad_2]
Source link
